Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatoblastoma: an investigation of diagnostic, prognostic, and therapeutic gene targets and biomarkers.

Pediatric research - 1 Jun 2026

Voskamp Sarah, Nelson Jennifer, Speck Karen Elizabeth

Abstract excerpt

BACKGROUND: Hepatoblastoma is the most common primary liver cancer in infants and children, with rising incidence worldwide over the past 30 years. Despite numerous advancements in understanding its genetic and epigenetic influences, a definitive etiology remains unidentified. This study investigates genetic signatures associated with hepatoblastoma, identifying potential causative mutations, therapeutic targets,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Expression Profiling
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatoblastoma

Share to Infant

Share to Liver Neoplasms

Share to Prognosis

Share to Wnt Signaling Pathway

Source

Identifiers

PMID: 41261163
DOI: 10.1038/s41390-025-04492-1

Genes

CENPA
DKK1
HMGA2
SLC7A11
WIF1
IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatoblastoma: an investigation of diagnostic, prognostic, and therapeutic gene targets and biomarkers.PMID 41261163Read ↗

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroupsSemantic proximity Read ↗

Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targetsSemantic proximity Read ↗

Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.Semantic proximity Read ↗

Biology of childhood hepatoblastoma and the search for novel treatmentsSemantic proximity Read ↗

Multi-dimensional profiling of hepatoblastomas and patient-derived tumor organoids uncovers tumor subpopulations with divergent WNT activation profiles and identifies pan-hepatoblastoma drug sensitivitiesSemantic proximity Read ↗

Genome-wide mapping of oncogenic pathways and genetic modifiers of chemotherapy using a high-risk hepatoblastoma genetic modelSemantic proximity Read ↗

Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.Semantic proximity Read ↗

Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.Semantic proximity Read ↗

Molecular genomic landscapes of hepatobiliary cancer.Semantic proximity Read ↗

Malignant Hepatoblast‐Like Cells Sustain Stemness via IGF2‐Dependent Cholesterol Accumulation in HepatoblastomaSemantic proximity Read ↗

Activation of Wnt and Myc signaling in hepatoblastoma.Semantic proximity Read ↗

Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.